These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 3780855
1. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Koltai M, Lepran I, Szekeres L, Viossat I, Chabrier E, Braquet P. Eur J Pharmacol; 1986 Oct 14; 130(1-2):133-6. PubMed ID: 3780855 [Abstract] [Full Text] [Related]
2. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Lagente V, Touvay C, Randon J, Desquand S, Cirino M, Vilain B, Lefort J, Braquet P, Vargaftig BB. Prostaglandins; 1987 Feb 14; 33(2):265-74. PubMed ID: 2438723 [Abstract] [Full Text] [Related]
3. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Touvay C, Etienne A, Braquet P. Agents Actions; 1986 Jan 14; 17(3-4):371-2. PubMed ID: 3754380 [Abstract] [Full Text] [Related]
4. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. Baranes J, Hellegouarch A, Le Hegarat M, Viossat I, Auguet M, Chabrier PE, Braquet P. Pharmacol Res Commun; 1986 Aug 14; 18(8):717-37. PubMed ID: 3763677 [Abstract] [Full Text] [Related]
5. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis. Berti F, Omini C, Rossoni G, Braquet P. Pharmacol Res Commun; 1986 Sep 14; 18(9):775-93. PubMed ID: 3099317 [Abstract] [Full Text] [Related]
7. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I, Chapelat M, Chabrier PE, Braquet P. Prostaglandins Leukot Essent Fatty Acids; 1989 Dec 14; 38(3):189-94. PubMed ID: 2622972 [Abstract] [Full Text] [Related]
8. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB. Eur J Pharmacol; 1986 Aug 07; 127(1-2):83-95. PubMed ID: 3019727 [Abstract] [Full Text] [Related]
9. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB. Pharmacol Res Commun; 1986 Aug 07; 18 Suppl():119-26. PubMed ID: 3774840 [Abstract] [Full Text] [Related]
10. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C, Vilain B, Taylor JE, Etienne A, Braquet P. Prog Lipid Res; 1986 Aug 07; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
16. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Braquet P. Adv Prostaglandin Thromboxane Leukot Res; 1986 Aug 07; 16():179-98. PubMed ID: 2949548 [No Abstract] [Full Text] [Related]